Live
Read now

Darwin Biosciences

Disease Detection Simplified

health AI / medtech / point-of-care diagnostics
StageSeed Round
Founded2020
Employees9
LocationBoulder, CO

About

Darwin Biosciences is redefining how infected individuals are detected by measuring an early immune response in saliva. Our hand-held device, developed in collaboration with the US Department of Defense and academic institutions, amplifies and detects human RNA in saliva that is broadly indicative of infection at the pre-symptomatic, asymptomatic, and symptomatic stages.

Founders

  • Nicholas Meyerson — Co-Founder and CEO
  • Qing Yang — Co-Founder & Scientific Consultant

Key features

Saliva-based samplingNon-invasive, point-of-care deviceDoes not require laboratory or power sourcesFast, accurate resultsDetects immune response to infection (pathogen-agnostic)Adaptable for nucleic acid detection across disease spacesEarly sepsis detectionMilitary-era inspired rapid, field-deployable diagnostics

Technologies

Biomarker panel for immune signatureSaliva-based samplingNucleic acid detectionPOC (point-of-care) diagnostic platform

Investors

University of Chicago New Venture Challenge

News

Browse similar startups

Related startups

Profile updated Jul 29, 2026. Sources: darwin.bio

ClinAdsby ClinsightBuilt for clinics

Your clinic’s marketing team, powered by AI.

On-brand ads, SEO, and social campaigns in one place.

Generate your first clinic ad for free
Clincyby ClinsightBuilt for practices

Get more revenue from the patients you already have.

Voice and SMS that follow up until lapsed patients are back on the schedule.

Book a Clincy call
DDS RecruitPowered by ClinsightDental recruiting

Your practice’s fractional recruiting team.

Dental-only search, run end to end, with placements guaranteed for a year.

Find your next hire